LumeNXT, Inc announced that seasoned business leader Marc Beer will be its new Chairman of the Board. The firm specializes in the research and development of exclusive and natively patented surgical illumination products for minimally invasive procedures. Marc will bring with him almost three decades of solid experience and expertise in business development and commercialization in the fields of medical devices, pharmaceuticals, biotechnology, and diagnostics with his latest leadership function.
Paul Rhyne, one of the founders of LumeNXT believes that Marc Beer has high levels of success in various startup companies that he has led through various growth stages. Rhyne values Beer’s vast experience in building companies and gearing those companies through international commercial releases and to the road of profitability. Marc Beer is also excited to be working with LumeNXT.
He said that he is proud that he will be working side by side with a team of committed and accomplished experts composed of engineers and surgeons. This is the team who has developed the proprietary product line that brought innovation and advancement in the field of surgical illumination through the company’s very own technology. Marc believes that the advances introduced by LumeNXT are crucial in the safety of the patients and professionals in conduction surgeries.
Marc is in line with the company and its perspective on the crucial role of its technology. He said that with LumeNXT’s technology, more surgeries performed using minimally invasive techniques will be carried out in the future. Surgeons that utilize targeted and guided illumination discovered that the technology helps them improve visualization and precision.
It also helps them to be flexible during the procedure compared to the customary and old school surgical procedures. LumeNXT, through its proprietary technology, provides an advanced illumination platform utilized as a heat-reduction tool to enhance surgical precision, more affordable and disposable alternatives, and safety through improved visualization.
Marc Beer is the founder and chief executive officer of Renovia Incorporated. He established the company with the objective of discovering and developing the first line of digital diagnostic and therapeutic medical devices for women who are suffering from PFD or pelvic floor disorder. Marc also founded and served as the chairman and driving force behind Minerva Neurosciences Inc. the company specializes in the development of a line of product candidates to find a cure for CNS or central nervous system diseases.
The company also conducts several late-stage clinical trials and develops advanced and innovative powerful compounds for various CNS diseases. This includes mood disorders, schizophrenia, Parkinson’s disease, major depressive disorders, and insomnia among others.
LumeN XT has named Mr. Marc as the new chairperson of this entity. In its basic operations, this firm deal with the development of the surgical illumination items that are used in the slight invasive surgical operations. Marc has a wide-ranging experience that extends for more than 25 years in the field of biotechnology. To this end, he is well versed when it comes to commercialization and development of surgical tools.
According to a proxy statement that was released by Mr. Marc, he expressed his gratitude to the team lumeNTX following its commitment to the provision of incomparable services in the market. However, he is positive that this success would not be attained without the devotion and willingness of the other engineers and other medical practitioners. Boiled down, these stakeholders have worked tirelessly to ensure that the surgical devices are advanced to reach greater heights while on the same note, ensuring that they are safe than anything else that was in use before. This implies that the development and improvement of illumination tools will continue to develop, and the performance of the lesser invasive surgical processes will be at its best.
Before he established lumeNTX, Mr. Beer served as the co-founder of the chairperson of the Minerva, which is a neuroscience Inc. In its primary operation, this firm deals with the development of neurosurgical devices. That are used to handle the central nervous system issues. He has also worked with other firms where he was responsible for the control and management of chronic diseases. To this end, he has been able to establish and support various medical institutions dealing with such issues. For instance, during his 11th year of work, Beer was able to guide the establishment of surgical tools that can help to establish issues affecting the women in their pelvic floor. During his last tenure with the Canadian Coloplast, he basically focused on the cross-functional synergies, custom integrated measures and the general strategies of this unit.
His Philanthropic Initiatives
Notably, Mr. Beer is among some of the most devoted leaders when it comes to giving back to the community he serves. As such, he uses the best part of his ability and expertise to help the community. His devotion and willingness to reach out the disadvantaged in the community has placed him in the various organization where he helps to show the way as the rest of the members’ step in to support his initiatives. However, this can be said to be the tip of the iceberg. This is because he has helped many individuals to deal with some of the most challenging ailments and on the same note, he has other initiatives that are meant to reach out to a significant number of clients how are in need of health services. Learn more: https://renoviainc.com/leadership/
Marc Beer, a renowned serial entrepreneur, and healthcare startup expert has been appointed to head the LumeNXT, Inc. Board. Beer joins the LumeNXT family as the Chairman of the Board of Directors. LumeNXT, Inc is a privately held company that deals with the development of surgical illumination devices that help enhance minimally invasive surgeries. The board of management of LumeNXT Inc saw Beer as the right candidate to fill the position since he had more than three decades worth of industry experience. Also, Beer was a specialist in device development and commercialization and had successfully helped start and grow numerous companies in the healthcare sector.
Marc Beer, while commenting on his appointment, said that he was very proud to have joined the LumeNXT dedicated and committed family. The family comprises of surgeons and engineers who work tirelessly to invent new technologies in the field of surgical illumination. Beer added that LumeNXT proprietary technology is of considerable significance as it has made surgeries safer. The firm relevance is going to be seen as more and more operations are performed with the minimally invasive technique that the firm prides itself in said Beer.
The targeted illumination technique that the firm has developed has helped enhance visualization, accuracy, and flexibility of surgeries as opposed to the traditional methods that were more difficult to achieve. The lumeNXT technology uses an advanced illumination technique known as the heat reduction mechanism. The mechanism helps improve surgical accuracy allows for low disposable cost options as well as enhances safety by boosting the visualization.
Paul Rhyne, the Co-founder of LumeNXT, Inc also made a statement in regards to Beer appointment. Rhyne said that Beer track record speaks for itself. He has been able to establish multiple companies successfully and has helped steer them to greater heights. Beer vast experience and in-depth knowledge in the industry will go a long way in ensuring that LumeNXT grows and becomes a profitable enterprise with global recognition.
About LumeNXT, Inc
LumeNXT, Inc is a private for-profit surgical device development company that utilizes highly innovative lighting technique and heat mechanism on its products. The firm creative innovations have gone a long way in ensuring that minimally invasive surgeries are more precise, efficient, and safe. Paul Rhyne serves at the helm of the company as the CEO and Co-founder.
About Marc Beer
Marc Beer is a seasoned businessman who has earned a reputation in the healthcare sector by successfully establishing multiple companies. Beer currently serves at the helm of Renovia Inc as the co-founder and CEO. Renovia Inc is a healthcare startup company that focuses on the development of diagnostic and therapeutic products for the care and treatment of pelvic floor disorders that affects millions of women worldwide. Besides Renovia Beer is the founder of ViaCell a biotechnology firm that he founded in 2000 and later sold it to Perkin Elmer in 2007. Beer has also served in senior capacities at Genzyme and Abbott Laboratories among others. Learn more: https://ideamensch.com/marc-beer/
Marc Beer is one of the better executives in healthcare. Recently, he has been appointed by LumeNXT Inc as the chairman of the board. The company specializes in development of surgical illumination for minimal invasive surgeries. With more than two decades as an executive in different capacities, Mark knows what it takes to get the job done. He also understands the value of good healthcare and how to make the lives of people easier. Target illumination is really great for surgeons because they need to be accurate in everything they do concerning the human body. As a surgeon, target illumination makes everything easier because it allows flexibility, increases visualisation and more. This is not his first rodeo, he has guided companies Like ViaCell, Renovia and multiple other startups to a successful state. As a result of his previous successes, there was no question how much value he could add to LumeNXT. Before Renovia and LumeNXT, he was the chair executive of Minerva, a company specialized in curing central nervous diseases. In other capacities, he’s also been the chairman of the board of directors of compensation committees and a member of the board of tertiary institutions in Florida. As an entrepreneur different things excite him, one of which is the disruptive nature of unconventional startups. According to him startups like Tesla and Airbnb have made waves in respective industries forming a new way of thinking and pushing the boundaries of what is considered normal. As a result their own conforming nature makes them stand out and thrive in profit at an impeccable level. That’s one thing he’s trying to achieve at LumeNXT and Renovia. He highlights that to get the best results you need the best people and as a CEO, he prides himself on taking time to recruit those individuals that can meet his short-term and long-term goals. His strive for success is unparalleled and he brings ideas to life by crossing his T’s and dotting his I’s. When bringing an idea to life, he makes sure that he understands the legal, financial and commercial implications of the product. In future, hopes the role of digital healthcare becomes the norm and surpasses conventional healthcare. It might take a decade or two for this changes to happen, but he notes that it will be remarkable for saving lives and increasing profits of his company. To increase efficiency, he makes sure that resource allocation is perfect and there is no wastage. This allows every department get sufficient resources to foster the development of a product. As a result it promotes efficiency and effectiveness. Learn more: https://renoviainc.com/
Dr. Ira Kirschenbaum is a doctor located primarily in Bronx, New York, specializing in orthopaedic surgery and adult reconstructive orthopaedic surgery. He earned a Bachelor of Science in Neuroscience from Brown University in 1979. His medical and orthopaedic education was completed at Albert Einstein College of Medicine of Yeshiva University in the Bronx. Currently, Dir. Ira Kirschenbaum is a chairman of orthopedics at the BronxCare Health System since 2008.
As a doctor, Dr. Ira Kirschenbaum has a busy schedule of coming up with new treatment systems, giving speeches, and helping out his patients. It is a wonder how he has enough time in his day to complete so many tasks, but he has a system that works out for him. He says that he devotes several hours a day to certain tasks that need to be completed that day. One consistent habit Dr. Ira Kirschenbaum maintains is checking emails and Linkedin in order to keep up with all medical news. Every day tends to bring different tasks, so some days are patient centered and other days are patient-centered value improvement projects.
Dr. Ira Kirschenbaum believes that the best way to bring ideas to life is by stating them and finding ways to execute them. By surrounding yourself with people who believe in your idea, you can find ways to improve it and set it into action. Another piece of advice he offers is one to his 18 year old self. He would tell his younger self to find other people following in his same footsteps and learn from them. No matter how good you think you are at what you do, mentors offer valuable resources and knowledge that should not be overlooked.
Dr. Ira Kirschenbaum remains optimistic about the future for medicine and healthcare. Although healthcare prices are rising, and many people see a health care crisis, he sees positive changes coming soon. He and his team have been working tirelessly towards new methods of healthcare that will benefit generations to come.
Marc Beer Renovia is among the owners of the Renovia Inc. which is an upcoming venture. It focuses on producing fresh commodities for pelvic floor disorders. This is after a 42 million agreement was concluded with a medical firm. The company is located in Boston and is producing diagnostic drugs to treat the disorder such as urinary incontinence. The initial product Renovia created, Leva, was approved by the FDA. Longwood Fund is an institution that concentrates on healthcare and it invested in Renovia from the start. The funds obtained from the company are used to improve therapeutic goods such as modernized Leva machine. He undertook his studies from Miami University where he graduated with a BS.
Besides being in the health sector, Marc Beer Renovia is a strategic consultant to OvaScience. The biotech firm is based in Waltham where it announced that it is partnering with Millendo Therapeutics to improve their products. He has over 25 years of experience in biotechnology and diagnostics. Moreover, he has a wide knowledge of pharmaceuticals which makes him a competent health expert. Renovia was established in 2016 and closed financing with prominent capital funds. This was in the best interest of every individual of the company so as to develop it.
Marc Beer Renovia came up with ViaCell in 2000 making him the ultimate owner. It is a biotechnology firm which focuses on the collection of umbilical cord blood stem cells. He managed the company for seven years, which made it prosper in the commercial sector. Under his management, the firm developed to contain over 300 workers. While managing the company, he had several tasks with Genzyme. Lately, he served as the vice president of Global Marketing in which he had a duty of launching multiple commodities. The products being presented were of rare illnesses on a worldwide measure. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html
Krishen Iyer is the CEO of Managed Benefits Services, a consulting firm that generates leads focused on health and dental insurance verticals, or “niche” marketing from a specific industry. Small changes can be made while tracking the impact they have over time. In 2019, some things have to change about current marketing techniques. One potential marketing technique when it comes to health insurance sales is to use Facebook as part of your marketing budget. Krishen Iyer advises to use Instagram as another option where you can promote your company in front of potential clients because Instagram leads to visibility. See Iyer’s marketing tips here https://chronicleweek.com/2018/09/krishen-iyer-top-marketing-tips/
For example, Krishen Iyer reminds us that you can advertise the fact that your clinic treats young children. Another way to promote your company is to use Chatbots, which interact with the user to send them in the right direction. New site visitors have easy access to any answers they may need. Video marketing is another 2019 marketing-savvy technique that you have the required expert-status to manage people’s health problems. Videos used the right way can promote an atmosphere of trust if you have adequate lighting in the room you film the video in. Live video is in a similar category when it comes to video marketing.
Live video on Youtube or Facebook has the means to get natural traffic onto your feed. Krishen Iyer says that videos can establish a person’s ability to answer questions on the air, giving real-time answers as well as feedback. You get a massive exposure, which generates attention out of it. Interactive content such as a blog post, articles, and email autoresponders seem to still have a place in a marketer’s toolkit. Text content can be laced with internal links that take people to where they want to go in an instant, as email marketing can still be used as well. Email marketing allows a professional to stay in contact with their clients, and it still works well in 2019. Adjusting your strategy is important to make it work over the long term. In 2019, voice search is also available as a marketing technique.
Marc Beer is a graduate from Miami University where he earned a BS; upon graduation he devoted himself to work in various fields including pharmaceuticals, biotech technology, diagnostics, devices among others. Marc Beer is the founding chairman of the board of directors at the Compensation Committee for the Good Start Genetics company, and NASDAQ: NERV. He has also enrolled at the Miami University Business advisory council to share his insight on various businesses related to the health sector, and even the Notre Dame Research advisory committee. While working at Genzyme, Marc Beer served multiple roles regarding sales and marketing of the company’s products as well as managing the Abbott Laboratories.
Later Marc Beer joined the ViaCell company to serve as the CEO; the company specialized in collecting, preserving and developing various umbilical cord blood stem cells. Marc Beer served for almost seven years, and at the end of his reign the company had employed more than 300 employees to manage its operations; he ensured ViaCell traded publicly in 2005. Later Marc Beer in partnership with MD, Yolanda Loire and Ramon Iglesias founded Renovia company with the aim of establishing various series of healthcare venture capital funds. Renovia company found Leva Product which is a significant treatment for the Pelvic muscles strengthening and rehabilitating. Marc Beer has overseen completion of Series A project that did very well in the healthcare venture capital fund.
Recently Marc Beer introduced Series B project by raising $42 million to construct Boston-based healthcare center for women. They have employed a group of experts to research and establish new therapeutic and diagnostic treatments which are made with modern technology. Marc Beer has targeted more than 250 million women across the globe who suffer from Pelvic disorders precisely Urinary incontinence. Renovia company has advanced technologies which serve several purposes; Marc Beer has stated their partnership with Longwood company to share this technology as well as the skills to support the Series B foundation.
By the end of Series B, Marc Beer aims to have developed a digital program through which patients can access treatments guidelines and awareness about various diseases. This program will also provide knowledge and skills on treatments for pelvic disorders. Marc Beer understands that many women suffering from pelvic disorders fail to seek medical support since its very expensive he has therefore ensured that long-term healthcare services offered at Renovia re relatively low and affordable even to the middle-class income people. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer
In addition to the new Series B foundation, Marc Beer has announced the appointing of John A. Fallon a medical director to the company’s board of directors. He has also contributed to the establishment of REDUCE center to study and come up with the next generation treatment methods.
Nitin Khanna was born in Ambala, India and led a strict life as a Colonel’s son. While in India, he attended The Lawrence School and Purdue where he earned his Bachelor’s and Master’s degrees in industrial engineering.
Due to his desire for success as an ambitious entrepreneur, Nitin Khanna moved to Portland, Oregon and started his own company in 2009 named MergerTech. Merger Tech is a bank where Nitin Khanna provides personal and comprehensive advice to other companies on acquisitions and mergers.
Nitin Khanna’s expertise on mergers and acquisitions lead to much higher selling prices than normal for his clients in the sales of Mutual Mobile, Simple and many others. These sales earned Nitin Khanna the #1 spot in mobile banking, ahead of other prestigious banks like the Bank of America as detailed here.
One of his second biggest accomplishments was Nitin Khanna’s key role in the growth of Saber, a company he co-founded in 1998. By 2007, Saber Corp had grown by $120 million and had over 1200 employees. It sold to EDS for $460 million in 2007.
After the sale of Saber Corp, Nitin Khanna took over the business operations at EDS that included Saber. When he left there, EDS had over 1500 employees and $300 million in revenue.
Aside from his business ventures, this highly regarded entrepreneur, Nitin Khanna, has donated to charities like medical foundations for leukemia, Children’s Museum and The Urban League. His contributions earned him the award of Portland’s Top 40 in 2002 by Governor John Kitzhaber. Because of his many accomplishments, Nitin Khanna is still highly regarded by all other entrepreneurs in Portland, Oregon today.
He has operated as the Vice President of Global Marketing at Genzyme Therapeutics Worldwide. He was the President of Global Marketing at Sanofi Company between 1996 and 2000. Marc is also remembered at Biostar where he worked as the vice president of sales and marketing. He was employed as the chief executive officer at Viacell and was responsible for all aspects of the company’s development. Marc has worked for many years over 25 years commercializing and developing the biotechnology and pharmaceutical industry.
Marc Beer is not a health professional, but his impact on the healthcare industry is significant. He tries his best in helping women in the society who suffer from pelvic disorders such as urinary incontinence. He has made a considerable achievement in boosting the health of women. After working for 25 years in investment companies, Marc launched his company known as Renovia Inc. The company specializes in manufacturing health products which are used in diagnosis and management pelvic disorders.
Last Year, Marc Beer raised a lot of money more than $ 42 billion which was meant to fund a project his company. Many reputable investors and investment companies raised the fund. The project aimed at introducing a new array of medical products which will be used in the management of pelvic conditions. The fundraising was meant to help women in Boston and the world at large who are suffering from these conditions.